Chile weighs adherence to AUGE guarantees
This article was originally published in Clinica
Executive Summary
Cataract surgery accounts for the bulk of the – albeit small – incidence of delayed care in Chile that is seen as being in breach of the country's "universal healthcare access guarantees" (AUGE) programme. This information, of which the health ministry is aware, is contained in a report produced for it by the Fonasa healthcare fund. The recently-released report constitutes the first appraisal of the level of adherence to AUGE's legally-binding principles. Fully 98.8% of services commissioned in 2008 were provided in accordance with its guarantees on timing. The remainder, ostensibly commissioned specifically as a result of "delay, increased risk or non-adherence", totalled almost 28,000 cases. 90% of these were covered by the private sector.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.